A modern approach to cancer treatment is inseparable from Interventional Oncology (IO), but despite the many advantages of Interventional Oncology, IO methods are insufficiently used in the Baltic countries for treating cancer patients. To ensure that all innovative cancer treatments are accessible to patients, it is necessary to identify challenges and address problems causing slower IO growth in the Baltic countries.
At this year’s Baltic States Radiology Congress, specialists from Lithuania, Latvia, and Estonia gathered to discuss the challenges and future of IO in the Baltic region. During a special session dedicated exclusively to Interventional Oncology, Dr. Algimantas Šimkaitis discussed the situation of IO in the Baltic countries and presented aspects of the economic benefits of this treatment. Dr. Donatas Jocius shared insights on his experience and challenges in implementing IO methods in Lithuania, Dr. Nauris Zdanovskis discussed Latvia’s progress, and Dr. Martin Reim shared his experience with IO methods in treating cancer patients in Estonia. Professor Stefan Weber discussed the revolutionary benefits of Qualitative Ablation in treating cancer patients across Europe, Professor Donatas Vajauskas presented SIRT (Selective Intra-Arterial Radiotherapy) in the treatment of oncology patients, and during the discussion moderated by Dr. Aina Kratovska, possible solutions were discussed to promote the development of IO and cooperation among specialists working in the IO field.
Interventional oncology (IO) represents a new approach to cancer treatment, but its potential has not yet been fully realized in the Baltic countries. Effective collaboration among specialists, knowledge sharing, and investments in healthcare innovations are essential to provide patients in Lithuania, Latvia, and Estonia with modern, minimally invasive, and life-saving treatment solutions.










